146 related articles for article (PubMed ID: 7188941)
21. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
22. Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.
Köpf-Maier P; Krahl D
Chem Biol Interact; 1983 Jun; 44(3):317-28. PubMed ID: 6872095
[TBL] [Abstract][Full Text] [Related]
23. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
Köpf-Maier P; Moormann A; Köpf H
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
[TBL] [Abstract][Full Text] [Related]
24. Antitumour metallocenes: structure-activity studies and interactions with biomolecules.
Harding MM; Mokdsi G
Curr Med Chem; 2000 Dec; 7(12):1289-303. PubMed ID: 11032972
[TBL] [Abstract][Full Text] [Related]
25. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
Silvestru C; Socaciu C; Bara A; Haiduc I
Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
[TBL] [Abstract][Full Text] [Related]
26. Ionic rhenocene derivatives with antitumor activity.
Köpf-Maier P; Klapötke T
Cancer Chemother Pharmacol; 1992; 29(5):361-6. PubMed ID: 1551174
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of beta-diketonato complexes of titanium, zirconium, and hafnium against chemically induced autochthonous colonic tumors in rats.
Bischoff H; Berger MR; Keppler BK; Schmähl D
J Cancer Res Clin Oncol; 1987; 113(5):446-50. PubMed ID: 3624300
[TBL] [Abstract][Full Text] [Related]
28. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
Zhou JX; He GH; Tao LX; Xu B
Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
[No Abstract] [Full Text] [Related]
29. Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides.
Köpf-Maier P; Wagner W; Köpf H
Naturwissenschaften; 1981 May; 68(5):272-3. PubMed ID: 7242686
[No Abstract] [Full Text] [Related]
30. Ferricenium complexes: a new type of water-soluble antitumor agent.
Köpf-Maier P; Köpf H; Neuse EW
J Cancer Res Clin Oncol; 1984; 108(3):336-40. PubMed ID: 6511806
[TBL] [Abstract][Full Text] [Related]
31. [Antitumor activity of total extract of "Amanita phalloides" Fr. on Ehrlich ascites tumor (author's transl)].
Villa L; Agostoni A
Tumori; 1972; 58(1):45-7. PubMed ID: 4677624
[No Abstract] [Full Text] [Related]
32. Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Thangavel S
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):178-85. PubMed ID: 14758001
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of 1.3-diketonato zirconium (IV) and hafnium (IV) complexes.
Keppler BK; Michels K
Arzneimittelforschung; 1985; 35(12):1837-9. PubMed ID: 4096740
[TBL] [Abstract][Full Text] [Related]
34. Organ distribution and pharmacokinetics of titanium after treatment with titanocene dichloride.
Köpf-Maier P; Brauchle U; Henssler A
Toxicology; 1988 Oct; 51(2-3):291-8. PubMed ID: 3176032
[TBL] [Abstract][Full Text] [Related]
35. [Antitumor activity of 2,6-bis(halomethyl)piperidines on Ehrlich ascites carcinoma (author's transl)].
Miyamoto K; Sanae F; Koshiura R; Tsuchiya T; Sawanishi H
Yakugaku Zasshi; 1977 Oct; 97(10):1150-4. PubMed ID: 592110
[No Abstract] [Full Text] [Related]
36. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
Sathisha MP; Budagumpi S; Kulkarni NV; Kurdekar GS; Revankar VK; Pai KS
Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
38. Ionic titanocene complexes: a new type of antitumor agent.
Köpf-Maier P; Neuse E; Klapötke T; Köpf H
Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis-inducing vanadocene compounds against human testicular cancer.
Ghosh P; D'Cruz OJ; Narla RK; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1536-45. PubMed ID: 10778987
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
Suzuki F
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1445-52. PubMed ID: 3874600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
